-
Loading metrics
CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40
-
Rui Wang ,
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Writing – original draft, Writing – review & editing
* E-mail: rwang@abbvie.com
Affiliation Abbvie, Cambridge Research Center, Cambridge, Massachusetts, United States of America
⨯ - Sean Graham,
- Ning Sun,
- Donna McCarthy,
- Ruoqi Peng,
- Jamie Erickson,
- Liz Oconnor,
- Xiaochun Zhu,
- Marc Wurbel,
- Robert Dunstan,
- Susan Westmoreland,
- Namjin Chung,
- Tariq Ghayur,
- Jijie Gu
http://orcid.org/0000-0001-8369-0817
CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40
- Rui Wang,
- Sean Graham,
- Ning Sun,
- Donna McCarthy,
- Ruoqi Peng,
- Jamie Erickson,
- Liz Oconnor,
- Xiaochun Zhu,
- Marc Wurbel,
- Robert Dunstan
x
- Published: March 10, 2020
- https://doi.org/10.1371/journal.pone.0228221